Carillon Tower Advisers’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-354,257
Closed -$30.9M 460
2019
Q4
$30.9M Hold
354,257
0.21% 174
2019
Q3
$26.3M Hold
354,257
0.18% 198
2019
Q2
$30.1M Sell
354,257
-34,250
-9% -$2.75M 0.21% 173
2019
Q1
$33.4M Buy
388,507
+215,007
+124% +$17.5M 0.24% 157
2018
Q4
$11M Buy
173,500
+17,625
+11% +$1.14M 0.09% 292
2018
Q3
$10.8M Buy
155,875
+14,150
+10% +$971K 0.08% 333
2018
Q2
$9.5M Sell
141,725
-85,025
-37% -$5.81M 0.07% 329
2018
Q1
$18.3M Buy
226,750
+26,565
+13% +$2.4M 0.14% 215
2017
Q4
$19K Buy
+200,185
New +$20.9M 0.2% 181

Other funds holding INCY

Carillon Tower Advisers's INCY Position: Q1 2020 in Review

Carillon Tower Advisers sold out of Incyte (INCY) in Q1 2020, closing a stake of 354,257 shares — an estimated $30.9M sold.

Carillon Tower Advisers first reported a position in INCY in Q4 2017 and held it in 9 quarters. The position peaked at $33.4M in Q1 2019. 491 funds tracked by Wall St. Rank hold INCY as of Q1 2020.

  • Carillon Tower Advisers reported no remaining Incyte position as of Q1 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 354,257 Incyte shares in Q1 2020, an estimated $30.9M.
  • Carillon Tower Advisers first reported a position in Incyte in Q4 2017 and held it in 9 quarters.
  • Carillon Tower Advisers's Incyte position peaked at $33.4M in Q1 2019.
  • 491 funds tracked by Wall St. Rank held Incyte as of Q1 2020.

Based on Carillon Tower Advisers's 13F filing for Q1 2020, filed 11 May 2020.